{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:28Z","timestamp":1786984288218,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ajem.2021.09.051","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T05:37:50Z","timestamp":1632721070000},"page":"646-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Efficacy and safety of tranexamic acid in aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"50","author":[{"given":"Tao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renmin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajem.2021.09.051_bb0005","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/jnnp.2007.117655","article-title":"Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends","volume":"78","author":"de Rooij","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ajem.2021.09.051_bb0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1474-4422(11)70017-5","article-title":"Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage","volume":"10","author":"Rinkel","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"10.1016\/j.ajem.2021.09.051_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2007.01.074","article-title":"Rebleeding from ruptured intracranial aneurysms in north Eastern Province of Japan. A cooperative study","volume":"258","author":"Tanno","year":"2007","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.ajem.2021.09.051_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.wneu.2012.06.023","article-title":"Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review","volume":"79","author":"Larsen","year":"2013","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ajem.2021.09.051_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001245","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","volume":"2","author":"Roos","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajem.2021.09.051_bb0030","first-page":"Cd001245","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","volume":"8","author":"Baharoglu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10269","key":"10.1016\/j.ajem.2021.09.051_bb0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(20)32518-6","article-title":"Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial","volume":"397","author":"Post","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.ajem.2021.09.051_bb0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.25259\/SNI_242_2021","article-title":"Commentary on Post, et al. Ultra-early tranexamic acid after subarachnoid hemorrhage: A randomized controlled trial","volume":"12","author":"Lo","year":"2021","journal-title":"Lancet Surg Neurol Int"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.051_bb0045","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.annemergmed.2014.06.004","article-title":"Are antifibrinolytic agents effective in the treatment of aneurysmal subarachnoid hemorrhage?","volume":"64","author":"Eastin","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2021.09.051_bb0050","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj."},{"issue":"20","key":"10.1016\/j.ajem.2021.09.051_bb0055","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"issue":"7109","key":"10.1016\/j.ajem.2021.09.051_bb0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj."},{"issue":"4","key":"10.1016\/j.ajem.2021.09.051_bb0065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","article-title":"Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study","volume":"97","author":"Hillman","year":"2002","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0070","first-page":"77","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial","volume":"54","author":"Roos","year":"2000","journal-title":"STAR Study Group Neurology"},{"issue":"1\u20132","key":"10.1016\/j.ajem.2021.09.051_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01402177","article-title":"Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study","volume":"102","author":"Tsementzis","year":"1990","journal-title":"Acta Neurochir (Wien)"},{"issue":"12","key":"10.1016\/j.ajem.2021.09.051_bb0080","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/01.STR.20.12.1674","article-title":"Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage","volume":"20","author":"Wijdicks","year":"1989","journal-title":"Stroke."},{"issue":"7","key":"10.1016\/j.ajem.2021.09.051_bb0085","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM198408163110703","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage","volume":"311","author":"Vermeulen","year":"1984","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.09.051_bb0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1227\/00006123-198102000-00004","article-title":"Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial","volume":"8","author":"Fodstad","year":"1981","journal-title":"Neurosurgery."},{"issue":"7","key":"10.1016\/j.ajem.2021.09.051_bb0095","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00415-014-7365-0","article-title":"Time intervals from subarachnoid hemorrhage to rebleed","volume":"261","author":"Germans","year":"2014","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.ajem.2021.09.051_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211868","article-title":"Short-term tranexamic acid treatment reduces in-hospital mortality in aneurysmal sub-arachnoid hemorrhage: A multicenter comparison study","volume":"14","author":"Post","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ajem.2021.09.051_bb0105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/emj.2005.023523","article-title":"Best evidence topic report. Antifibrinolytics for the initial management of sub arachnoid haemorrhage","volume":"22","author":"Carley","year":"2005","journal-title":"Emerg Med J"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.051_bb0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12028-008-9088-5","article-title":"Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage","volume":"8","author":"Chwajol","year":"2008","journal-title":"Neurocrit Care"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/1658-354X.146304","article-title":"Effect of low dose tranexamic acid on intra-operative blood loss in neurosurgical patients","volume":"9","author":"Vel","year":"2015","journal-title":"Saudi J Anaesth"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.051_bb0120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/bja\/aeh227","article-title":"Perioperative systemic haemostatic agents","volume":"93","author":"Mahdy","year":"2004","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.051_bb0125","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke."},{"issue":"6","key":"10.1016\/j.ajem.2021.09.051_bb0130","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc6173","article-title":"Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial","volume":"11","author":"Jimenez","year":"2007","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.051_bb0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1538\/expanim.17-0143","article-title":"Anti-inflammatory effect of tranexamic acid against trauma-hemorrhagic shock-induced acute lung injury in rats","volume":"67","author":"Teng","year":"2018","journal-title":"Exp Anim"},{"issue":"2","key":"10.1016\/j.ajem.2021.09.051_bb0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/TA.0000000000001056","article-title":"Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock","volume":"81","author":"Peng","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"issue":"1\u20132","key":"10.1016\/j.ajem.2021.09.051_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01400969","article-title":"Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA)","volume":"56","author":"Fodstad","year":"1981","journal-title":"Acta Neurochir"},{"issue":"10","key":"10.1016\/j.ajem.2021.09.051_bb0150","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/WNL.37.10.1586","article-title":"Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the cooperative aneurysm study","volume":"37","author":"Adams","year":"1987","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.ajem.2021.09.051_bb0155","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.STR.19.10.1250","article-title":"Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage","volume":"19","author":"Hijdra","year":"1988","journal-title":"Stroke."},{"issue":"3\u20134","key":"10.1016\/j.ajem.2021.09.051_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01402885","article-title":"Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study","volume":"93","author":"Pinna","year":"1988","journal-title":"Acta Neurochir"},{"issue":"10","key":"10.1016\/j.ajem.2021.09.051_bb0165","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke."},{"issue":"2","key":"10.1016\/j.ajem.2021.09.051_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000346087","article-title":"European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage","volume":"35","author":"Steiner","year":"2013","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"10.1016\/j.ajem.2021.09.051_bb0175","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1055\/s-0037-1604089","article-title":"Evidence for the use of tranexamic acid in subarachnoid and subdural hemorrhage: a systematic review","volume":"43","author":"Anker-Moller","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/S0317167100039160","article-title":"Acute hydrocephalus following aneurysmal subarachnoid hemorrhage","volume":"23","author":"Mehta","year":"1996","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.051_bb0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/01.STR.20.6.747","article-title":"Management problems in acute hydrocephalus after subarachnoid hemorrhage","volume":"20","author":"Hasan","year":"1989","journal-title":"Stroke."},{"issue":"5","key":"10.1016\/j.ajem.2021.09.051_bb0190","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3171\/jns.2002.97.5.1042","article-title":"Preoperative ventriculostomy and rebleeding after aneurysmal subarachnoid hemorrhage","volume":"97","author":"McIver","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ajem.2021.09.051_bb0195","first-page":"8584753","article-title":"Hydrocephalus after subarachnoid hemorrhage: pathophysiology, diagnosis, and treatment","volume":"2017","author":"Chen","year":"2017","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10143-005-0423-4","article-title":"Review of the literature regarding the relationship of rebleeding and external ventricular drainage in patients with subarachnoid hemorrhage of aneurysmal origin","volume":"29","author":"Fountas","year":"2006","journal-title":"Neurosurg Rev"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.051_bb0205","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3171\/jns.1992.76.3.0422","article-title":"The relationship of ventricular drainage to aneurysmal rebleeding","volume":"76","author":"Par\u00e9","year":"1992","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ajem.2021.09.051_bb0210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-227X-13-20","article-title":"Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial","volume":"13","author":"Yutthakasemsunt","year":"2013","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.ajem.2021.09.051_bb0215","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.wneu.2017.10.075","article-title":"Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury","volume":"109","author":"Fakharian","year":"2018","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0220","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/s13054-020-03243-4","article-title":"Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial","volume":"24","author":"Brenner","year":"2020","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.051_bb0225","first-page":"612","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) a randomised, placebo-controlled trial","volume":"59","author":"Williams-Johnson","year":"2010","journal-title":"West Indian Med J"},{"issue":"4","key":"10.1016\/j.ajem.2021.09.051_bb0230","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00068-018-0974-z","article-title":"Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients","volume":"45","author":"Chakroun-Walha","year":"2019","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12873-020-00335-w","article-title":"Outcomes of tranexamic acid administration in military trauma patients with intracranial hemorrhage: a cohort study","volume":"20","author":"Walker","year":"2020","journal-title":"BMC Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12883-020-01694-4","article-title":"Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury - meta-analysis of randomized controlled trials","volume":"20","author":"July","year":"2020","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0245","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00134-020-06279-w","article-title":"Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials","volume":"47","author":"Lawati","year":"2021","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.051_bb0250","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.410330310","article-title":"Epileptic seizures after subarachnoid hemorrhage","volume":"33","author":"Hasan","year":"1993","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ajem.2021.09.051_bb0255","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12028-011-9584-x","article-title":"Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage","volume":"15","author":"Lanzino","year":"2011","journal-title":"Neurocrit Care"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s701-002-8275-z","article-title":"Epileptic seizures following cortical application of fibrin sealants containing tranexamic acid in rats","volume":"144","author":"Schlag","year":"2002","journal-title":"Acta Neurochir"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.24558","article-title":"Tranexamic acid-associated seizures: causes and treatment","volume":"79","author":"Lecker","year":"2016","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.051_bb0270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/jpet.301.1.168","article-title":"Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(a) receptor antagonistic effect","volume":"301","author":"Furtm\u00fcller","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.ajem.2021.09.051_bb0275","first-page":"633","article-title":"Seizures associated with tranexamic acid for cardiac surgery: a meta-analysis of randomized and non-randomized studies","volume":"58","author":"Takagi","year":"2017","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"10","key":"10.1016\/j.ajem.2021.09.051_bb0280","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","author":"Rowell","year":"2020","journal-title":"Jama."}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721007889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721007889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:02:53Z","timestamp":1760025773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721007889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":56,"alternative-id":["S0735675721007889"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.09.051","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-753306\/v1","asserted-by":"object"}]},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of tranexamic acid in aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.09.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}